Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CLVTNASDAQ:DLONYSE:DXCNASDAQ:NUTX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLVTClarivate$3.99-5.0%$4.10$3.04▼$7.15$2.87B1.475.20 million shs7.31 million shsDLODLocal$10.26+0.6%$9.98$6.57▼$14.26$2.91B1.11.31 million shs2.47 million shsDXCDXC Technology$14.66+3.1%$15.36$13.44▼$24.83$2.58B1.221.49 million shs1.96 million shsNUTXNutex Health$116.85+2.6%$138.10$4.16▼$184.28$632.67M0.0378,845 shs141,965 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLVTClarivate0.00%-0.83%+2.64%+1.21%-24.55%DLODLocal0.00%+3.98%-9.41%+5.15%+36.36%DXCDXC Technology0.00%-8.45%-3.40%-16.03%-23.99%NUTXNutex Health0.00%-6.86%-28.80%+91.41%+1,934.48%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLVTClarivate3.5987 of 5 stars2.83.00.00.01.43.33.1DLODLocal3.3883 of 5 stars2.21.00.00.03.23.33.8DXCDXC Technology4.0425 of 5 stars2.94.00.02.01.91.71.9NUTXNutex Health3.3303 of 5 stars3.52.00.00.02.93.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLVTClarivate 1.67Reduce$5.0025.31% UpsideDLODLocal 2.38Hold$12.4521.35% UpsideDXCDXC Technology 1.83Reduce$17.0015.96% UpsideNUTXNutex Health 3.00Buy$262.50124.65% UpsideCurrent Analyst Ratings BreakdownLatest NUTX, DLO, CLVT, and DXC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025DLODLocalTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold$12.005/27/2025DLODLocalCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.605/21/2025DXCDXC TechnologyJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$22.00 ➝ $18.005/20/2025NUTXNutex HealthMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$100.00 ➝ $225.005/15/2025DLODLocalSusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetPositive ➝ Positive$16.00 ➝ $18.005/15/2025DXCDXC TechnologyRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$27.00 ➝ $18.005/15/2025DXCDXC TechnologyMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$22.00 ➝ $16.005/15/2025DXCDXC TechnologyBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$26.00 ➝ $17.005/15/2025NUTXNutex HealthBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$150.00 ➝ $300.005/12/2025DXCDXC TechnologyGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral4/23/2025DXCDXC TechnologySusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$23.00 ➝ $16.00(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLVTClarivate$2.56B1.07$1.60 per share2.50$7.23 per share0.55DLODLocal$745.97M3.93$0.61 per share16.83$1.71 per share6.00DXCDXC Technology$12.87B0.21$11.11 per share1.32$19.28 per share0.76NUTXNutex Health$479.95M1.35$13.51 per share8.65$37.13 per share3.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLVTClarivate-$636.70M-$0.97N/A5.87N/A-26.32%8.75%3.96%8/5/2025 (Estimated)DLODLocal$120.42M$0.4920.9418.000.9719.19%37.55%15.19%8/13/2025 (Estimated)DXCDXC Technology$389M$2.116.954.433.753.02%19.36%4.77%8/6/2025 (Estimated)NUTXNutex Health$52.18M$11.899.83∞N/A10.76%42.08%11.80%8/6/2025 (Estimated)Latest NUTX, DLO, CLVT, and DXC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025DLODLocal$0.12$0.15+$0.03$0.15$213.52 million$216.76 million5/14/2025Q4 2025DXCDXC Technology$0.76$0.84+$0.08$1.42$3.13 billion$3.17 billion5/13/2025Q1 2025NUTXNutex Health-$0.15$2.56+$2.71$2.56$81.09 million$211.79 million4/29/2025Q1 2025CLVTClarivate$0.12$0.14+$0.02-$0.15$574.03 million$593.70 million3/31/2025Q4 2024NUTXNutex Health-$0.09$11.12+$11.21$11.12$81.13 million$81.30 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLVTClarivateN/AN/AN/AN/AN/ADLODLocalN/AN/AN/AN/AN/ADXCDXC TechnologyN/AN/AN/AN/AN/ANUTXNutex HealthN/AN/AN/AN/AN/ALatest NUTX, DLO, CLVT, and DXC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/13/2025DLODLocal--$0.52515/27/20255/27/20256/10/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLVTClarivate0.900.880.88DLODLocal0.011.651.65DXCDXC Technology0.861.221.22NUTXNutex Health1.022.272.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLVTClarivate85.72%DLODLocal90.13%DXCDXC Technology96.20%NUTXNutex Health5.32%Insider OwnershipCompanyInsider OwnershipCLVTClarivate23.18%DLODLocal45.44%DXCDXC Technology0.61%NUTXNutex Health36.92%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLVTClarivate12,000683.09 million524.75 millionOptionableDLODLocal1,095285.48 million155.76 millionOptionableDXCDXC Technology120,000181.27 million180.16 millionOptionableNUTXNutex Health1,1505.56 million3.50 millionNot OptionableNUTX, DLO, CLVT, and DXC HeadlinesRecent News About These CompaniesNutex Health Leverages Arbitration To Unlock Hidden ValueJune 19, 2025 | seekingalpha.comNutex Health (NASDAQ:NUTX) Trading Down 5% - Here's WhyJune 17, 2025 | marketbeat.comNutex Health (NASDAQ:NUTX) Trading 5.9% Higher - What's Next?June 12, 2025 | marketbeat.comMillennium Management LLC Acquires Shares of 6,727 Nutex Health Inc. (NASDAQ:NUTX)June 12, 2025 | marketbeat.comNutex Health (NASDAQ:NUTX) Shares Down 5.9% - Here's WhyJune 10, 2025 | marketbeat.com8,986 Shares in Nutex Health Inc. (NASDAQ:NUTX) Bought by Squarepoint Ops LLCJune 7, 2025 | marketbeat.comNutex Health (NASDAQ:NUTX) Sees Large Volume Increase - Here's What HappenedJune 6, 2025 | marketbeat.comNutex Health (NASDAQ:NUTX) Trading Down 4.4% - Here's WhyJune 3, 2025 | marketbeat.comNorthern Trust Corp Takes $200,000 Position in Nutex Health Inc. (NASDAQ:NUTX)June 3, 2025 | marketbeat.comNUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETINGJune 2, 2025 | prnewswire.comShort Interest in Nutex Health Inc. (NASDAQ:NUTX) Rises By 76.0%June 1, 2025 | marketbeat.comNutex Health Inc.: High-Growth Healthcare Innovator With Strong MomentumMay 29, 2025 | seekingalpha.comNutex Health Inc.: High-Growth Healthcare Innovator With Strong MomentumMay 29, 2025 | seekingalpha.comNutex Health appoints Grant Thornton as new auditorMay 23, 2025 | uk.investing.comOMERS ADMINISTRATION Corp Buys Shares of 7,300 Nutex Health Inc. (NASDAQ:NUTX)May 23, 2025 | marketbeat.comNUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITORMay 22, 2025 | prnewswire.comHouston's Nutex plans first San Antonio hospital, eyes potential further expansionMay 20, 2025 | bizjournals.comShuttered health center finds new life in first 'micro' hospital in San AntonioMay 20, 2025 | msn.comNutex Health: The Stock Has Gotten Ahead Of Itself As Arbitration Revenue NormalizesMay 16, 2025 | seekingalpha.comNutex Health, Inc. (NASDAQ:NUTX) Q1 2025 Earnings Call TranscriptMay 16, 2025 | msn.comNutex Health Inc (NUTX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion ...May 16, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingTop 4 Growth Stocks With Momentum and Room to RunBy Ryan Hasson | June 16, 2025View Top 4 Growth Stocks With Momentum and Room to RunNUTX, DLO, CLVT, and DXC Company DescriptionsClarivate NYSE:CLVT$3.99 -0.21 (-5.00%) Closing price 03:59 PM EasternExtended Trading$4.03 +0.04 (+0.88%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.DLocal NASDAQ:DLO$10.26 +0.06 (+0.59%) Closing price 04:00 PM EasternExtended Trading$10.38 +0.12 (+1.12%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DLocal Limited operates a payment processing platform worldwide. The company offers pay-in solution which the business and get paid for their products and services through various payment methods, including international and local cards, online bank transfers and direct debit, cash, and alternative payment methods. It also provides pay-out solution used for merchants to scale pay-out operations. In addition, the company offers dLocal for Platforms, an end-to-end payment solution that offers a range of services to help platforms manage payments. It serves its products to commerce, streaming, ride-hailing, financial services, advertising, SaaS, travel, e-learning, on-demand delivery, and gaming and crypto industries. DLocal Limited was founded in 2016 and is headquartered in Montevideo, Uruguay.DXC Technology NYSE:DXC$14.66 +0.44 (+3.09%) Closing price 03:59 PM EasternExtended Trading$14.66 +0.00 (+0.03%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DXC Technology Company, together with its subsidiaries, provides information technology services and solutions in the United States, the United Kingdom, rest of Europe, Australia, and internationally. It operates in two segments, Global Business Services (GBS) and Global Infrastructure Services (GIS). The GBS segment offers a portfolio of analytics services and extensive partner ecosystem that help its customers to gain insights, automate operations, and accelerate their transformation journeys; and software engineering, consulting, and data analytics solutions, which enable businesses to run and manage their mission-critical functions, transform their operations, and develop new ways of doing business. This segment also simplifies, modernize, and accelerate mission-critical applications that support business agility and growth through applications services; provides proprietary modular insurance software and platforms; and operates a wide spectrum of insurance business process services, as well as helps to operate and improve bank cards, payment and lending process and operations, and customer experiences. The GIS segment offers security services, such as IT security, operations and culture for migrating to the cloud, protecting data with a zero-trust strategy, and manage a security operation center; and cloud infrastructure and IT outsourcing services. This segment also delivers a consumer-like experience, centralize IT management, and support services, as well as improves the total cost of ownership; and orchestrates hybrid cloud and multicloud environments. The company markets and sells its products through direct sales force to commercial businesses and public sector enterprises. DXC Technology Company was founded in 1959 and is headquartered in Ashburn, Virginia.Nutex Health NASDAQ:NUTX$116.85 +2.96 (+2.60%) Closing price 04:00 PM EasternExtended Trading$117.40 +0.55 (+0.47%) As of 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
